Skip to content
MedsAcross

Medicine

Tapentadol 50 mg tablet

Tapentadol · Oral
Available on requestPrescription onlyUS FDAControlled, schedule CIIGeneric name

Tapentadol 50 mg tablet is a generic prescription medicine for oral use, made by 4 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20ºC to 25°C (68°F to 77ºF), excursions permitted to 15ºC to 30ºC…

Key facts

Active ingredient (INN)
Tapentadol
Brand
Sold under the generic name
Strength
50 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets and 1 more
Manufacturers
Novadoz PharmaceuticalsIndiaAvKAREEpic PharmaHikma Pharmaceuticals
Origin register
US FDA, United States
Storage
Store at 20ºC to 25°C (68°F to 77ºF), excursions permitted to 15ºC to 30ºC (59ºF to 86ºF). Protect from moisture. Store tapentadol tablets securely and dispose of properly. imprint.jpg imprint.jpg imprint.jpg
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Schedule CII
ATC code
N02AX06 Tapentadol
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
31 December 2021
Identifiers
RxCUI 825409, 825411, 825413DailyMed set ID fecd2104-5bf3-47ed-a6f0-5c6ebb0a17b4, 5b769a76-5ca5-b2e9-e063-6394a90a1b1b, d4c5938a-68f0-46d2-9bad-8988d5724b09 +1NDC 42806-626, 73190-081, 72205-369 +1Application ANDA214378, ANDA220865, NDA022304

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 tablet, film coated in 1 bottle72205-369-91Novadoz PharmaceuticalsIndia3 September 2026
100 tablet, film coated in 1 bottle42806-626-01Epic Pharma31 December 2021
100 tablet, film coated in 1 bottle, plastic0054-0942-25Hikma Pharmaceuticals15 December 2025
100 tablet, film coated in 1 bottle73190-081-01AvKARE14 September 2026

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 20 November 2008Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Tapentadol 50 mg tablet.

Compare 1

Other strengths and forms of Tapentadol

Clinical summary

Tapentadol is an opioid agonist indicated for the management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate in adults, among other approved uses. MedsAcross supplies Tapentadol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Tapentadol

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Tapentadol 50 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.